Cover Image
Market Research Report
Product code 
1036889

Medical Exoskeleton Market by Component (Hardware (Sensor, Actuator, Control System, Power Source), Software), Type (Powered, Passive), Extremities (Lower, Upper and Full Body) & Mobility (Mobile, Stationary) - Global Forecasts to 2026

Published: | MarketsandMarkets | 175 Pages | Delivery time: 1-2 business days

Price

Back to Top
Medical Exoskeleton Market by Component (Hardware (Sensor, Actuator, Control System, Power Source), Software), Type (Powered, Passive), Extremities (Lower, Upper and Full Body) & Mobility (Mobile, Stationary) - Global Forecasts to 2026
Published: November 15, 2021
MarketsandMarkets
Content info: 175 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

The global medical exoskeleton market size is estimated to be USD 1.0 billion by 2026, from USD 0.2 billion in 2021, at a CAGR of 45.0%. The growth of this market is mainly driven by factors such as the increasing number of people with physical disabilities and subsequent growth in the demand for effective rehabilitation approaches; agreements and collaborations among companies and research organizations for the development of the exoskeleton technology, and increasing insurance coverage for medical exoskeletons in several countries driving the growth of the medical exoskeleton market. However, the high cost of medical exoskeletons may restrict market growth to a certain extent.

"The hardware segment is expected to account for the largest share 78.57% of the medical exoskeleton market in 2020."

The devices segment is expected to hold the largest share 74.9% of the medical exoskeleton market in 2020. This is mainly due to the rising incidence of neurological, neurodegenerative, psychotic, and sleep disorders; the need for early diagnosis; the availability of innovative portable and wearable home-based monitoring devices; and increasing patient awareness.

"The lower extremity segment to register the highest growth rate in the forecast period."

In 2020, the lower extremity medical exoskeletons segment is expected to account for a larger share of 63.0% of the market. Lower extremity exoskeletons provide stability to paralyzed and geriatric patients and offer weight-bearing and locomotion capabilities. As a result, their adoption is higher in the rehabilitation of patients.

"North America to be the largest regional segment in the medical exoskeleton market during the forecast period."

Based on the region, the global medical exoskeleton market is divided into North America, Europe, Asia, and the RoW. In 2020, North America is expected to dominate the market with a share of 44.42%. The growing geriatric population, increasing demand for self-assist exoskeletons, high prevalence of stroke, and growing number of spinal cord injuries (SCI) are the key factors driving the growth of the medical exoskeleton market in this region.

Breakdown of primaries

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 (40%), Tier 2 (25%), and Tier 3 (35%)
  • By Designation: C-level Executives (35%), Directors (28%), and Others (37%)
  • By Region: North America (28%), Europe (22%), Asia (40%), and the RoW (10%)

The medical exoskeleton market is dominated by a few globally established players such as Ekso Bionics Holdings, Inc. (US), ReWalk Robotics Ltd. (Israel), Parker Hannifin Corp (US), CYBERDYNE Inc. (Japan), Bionik Laboratories Corp (Canada), Rex Bionics Ltd. (UK), B-TEMIA Inc. (Canada), Hocoma AG (a subsidiary of DIH Technologies) (Switzerland), Wearable Robotics SRL (Italy), Gogoa Mobility Robots SL (Spain), and ExoAtlet (Luxembourg).

Research Coverage:

This report provides a picture of the global medical exoskeleton market. It aims at estimating the size and future growth potential of the market across different segments, such as component, type, extremity, mobility and structure. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the medical exoskeleton market and provides them information on key market drivers, restraints, challenges, and opportunities.

Product Code: MD 6481

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 MEDICAL EXOSKELETON MARKET SEGMENTATION
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key industry insights
      • 2.1.2.2 Breakdown of primaries
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 5 COMPANY REVENUE SHARE ANALYSIS ILLUSTRATION: MEDICAL EXOSKELETON MARKET
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach for arriving at market size using bottom-up analysis (demand side)
    • FIGURE 6 MEDICAL EXOSKELETON MARKET: BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
      • 2.2.2.1 Approach for arriving at market size using top-down analysis (supply side)
    • FIGURE 7 MEDICAL EXOSKELETON MARKET: TOP-DOWN APPROACH
    • 2.2.3 GROWTH FORECAST
    • FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL EXOSKELETON MARKET (2021-2026)
    • FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 RESEARCH ASSUMPTIONS
    • FIGURE 11 STUDY ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
    • TABLE 1 LIMITATIONS & ASSOCIATED RISKS

3 EXECUTIVE SUMMARY

    • FIGURE 12 MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2026 (USD MILLION)
    • FIGURE 13 MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • FIGURE 14 MEDICAL EXOSKELETON MARKET, BY EXTREMITY, 2021-2026 (USD MILLION)
    • FIGURE 15 MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2026 (USD MILLION)
    • FIGURE 16 GEOGRAPHIC SNAPSHOT: MEDICAL EXOSKELETON MARKET

4 PREMIUM INSIGHTS

  • 4.1 MEDICAL EXOSKELETON MARKET: OVERVIEW
    • FIGURE 17 INCREASING DEMAND FOR EFFECTIVE REHABILITATION APPROACHES IS DRIVING MARKET GROWTH
  • 4.2 MEDICAL EXOSKELETON MARKET, BY HARDWARE TYPE & REGION
    • FIGURE 18 ACTUATORS TO HOLD LARGEST SHARE OF MEDICAL EXOSKELETON HARDWARE MARKET IN 2021
  • 4.3 MEDICAL EXOSKELETON MARKET, BY EXTREMITY
    • FIGURE 19 UPPER EXTREMITY SEGMENT TO GROW AT HIGHEST CAGR FROM 2021 TO 2026
  • 4.4 GEOGRAPHIC SNAPSHOT: MEDICAL EXOSKELETON MARKET
    • FIGURE 20 ASIA TO BE FASTEST-GROWING REGIONAL SEGMENT DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 21 MEDICAL EXOSKELETON MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing number of people with physical disabilities and subsequent growth in demand for effective rehabilitation approaches
    • FIGURE 22 AGING POPULATION, BY REGION, 2019 VS. 2050
    • FIGURE 23 PERCENTAGE OF DISABLED PEOPLE IN US, 2015-2020
    • FIGURE 24 PERCENTAGE OF DISABLED PEOPLE IN US, BY AGE GROUP, 2018
    • FIGURE 25 PERCENTAGE OF DISABLED PEOPLE IN US, BY TYPE OF DISABILITY, 2018
      • 5.2.1.2 Agreements and collaborations among companies and research organizations for development of exoskeleton technology
      • 5.2.1.3 Huge investments for development of exoskeleton technology
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Regulatory challenges for securing approvals for medical exoskeletons
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Introduction of soft actuators
      • 5.2.3.2 Increasing insurance coverage for medical exoskeletons in several countries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 High equipment cost
    • TABLE 2 COST OF MEDICAL EXOSKELETONS
      • 5.2.4.2 Safety concerns associated with medical exoskeletons
      • 5.2.4.3 Long-term power supply requirements
  • 5.3 IMPACT OF COVID-19 ON MEDICAL EXOSKELETON MARKET
    • 5.3.1 VALUE CHAIN ANALYSIS
    • FIGURE 26 VALUE CHAIN ANALYSIS OF MEDICAL EXOSKELETON MARKET
    • 5.3.2 ECOSYSTEM
    • FIGURE 27 MEDICAL EXOSKELETON ECOSYSTEM
    • TABLE 3 MEDICAL EXOSKELETON MARKET SUPPLY CHAIN
  • 5.4 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 MEDICAL EXOSKELETON MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.4.1 DEGREE OF COMPETITION
    • 5.4.2 BARGAINING POWER OF SUPPLIERS
    • 5.4.3 BARGAINING POWER OF BUYERS
    • 5.4.4 THREAT OF SUBSTITUTES
    • 5.4.5 THREAT OF NEW ENTRANTS
  • 5.5 CASE STUDIES FOR MEDICAL EXOSKELETON MARKET
    • 5.5.1 PEER-REVIEWED CASE STUDY DEMONSTRATES VARIOUS HEALTH IMPROVEMENTS FOLLOWING REWALK EXOSKELETON USE
    • 5.5.2 EKSO BIONICS IMPROVES PATIENT MOBILITY WITH HELP OF VODAFONE-MANAGED IOT CONNECTIVITY PLATFORM
    • 5.5.3 RLS MAGNETIC ENCODERS ENABLED MARSI BIONICS TO DESIGN AND BUILD EXOSKELETON ORTHOPAEDIC DEVICES
  • 5.6 TECHNOLOGY ANALYSIS
  • 5.7 FUTURE TRENDS OF MEDICAL EXOSKELETON MARKET
  • 5.8 PATENT ANALYSIS
  • 5.9 STANDARDS AND REGULATIONS RELATED TO MEDICAL EXOSKELETON MARKET

6 MEDICAL EXOSKELETON MARKET, BY COMPONENT

  • 6.1 INTRODUCTION
    • TABLE 5 MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
  • 6.2 HARDWARE
    • TABLE 6 MEDICAL EXOSKELETON HARDWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 7 EXOSKELETON MARKET FOR HARDWARE, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.1 SENSORS
      • 6.2.1.1 Sensors help exoskeletons to acquire knowledge about surrounding environment
    • TABLE 8 MEDICAL EXOSKELETON HARDWARE MARKET FOR SENSORS , BY REGION, 2019-2026 (USD MILLION)
      • 6.2.1.2 Gyroscopes
        • 6.2.1.2.1 Gyroscopes are used in exoskeletons for orientation and rotation measurements
      • 6.2.1.3 Microphones
        • 6.2.1.3.1 Microphones assist medical exoskeletons in sound source localization by separating unwanted sound signals from other positions
      • 6.2.1.4 Accelerometers
        • 6.2.1.4.1 Accelerometers are integrated into medical exoskeletons for measurement of non-gravitational acceleration forces
      • 6.2.1.5 Tilt sensors
        • 6.2.1.5.1 Tilt sensors are used in medical exoskeletons to measure tilt angle with respect to Earth's ground plane
      • 6.2.1.6 Force/torque sensors
        • 6.2.1.6.1 Force/torque sensors help medical exoskeletons control interaction with objects in manipulation tasks
      • 6.2.1.7 Position sensors
        • 6.2.1.7.1 Position sensors are used to measure distance traveled by medical exoskeletons from their origin
      • 6.2.1.8 Others
    • 6.2.2 ACTUATORS
      • 6.2.2.1 Actuators are used to set systems in motion and control their mechanism
    • TABLE 9 MEDICAL EXOSKELETON HARDWARE MARKET FOR ACTUATORS, BY REGION, 2019-2026 (USD MILLION)
      • 6.2.2.2 Electrical
        • 6.2.2.2.1 Electrical actuators use motors to convert electrical energy into mechanical energy
      • 6.2.2.3 Pneumatic
        • 6.2.2.3.1 Pneumatic actuators convert electric energy into mechanical motion and are similar to capacitors in operation
      • 6.2.2.4 Hydraulic
        • 6.2.2.4.1 Hydraulic actuators are used in medical exoskeleton applications where heavy force and speed are required
      • 6.2.2.5 Piezoelectric
        • 6.2.2.5.1 Piezoelectric actuators use converse piezoelectric effect for precise positioning of systems, ultrasonic actuators, and microactuators in exoskeletons
    • 6.2.3 POWER SOURCES
      • 6.2.3.1 Exoskeletons mainly use lead-acid batteries, fuel cells, and lithium-ion batteries for electrical connectivity
    • TABLE 10 MEDICAL EXOSKELETON HARDWARE MARKET FOR POWER SOURCES , BY REGION, 2019-2026 (USD MILLION)
    • 6.2.4 CONTROL SYSTEMS/CONTROLLERS
      • 6.2.4.1 Controllers allow all parts of exoskeletons to operate together
    • TABLE 11 MEDICAL EXOSKELETON HARDWARE MARKET FOR CONTROL SYSTEMS, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.5 OTHERS
    • TABLE 12 MEDICAL EXOSKELETON HARDWARE MARKET FOR OTHER HARDWARE COMPONENTS, BY REGION, 2019-2026 (USD MILLION)
  • 6.3 SOFTWARE
    • 6.3.1 SOFTWARE HELP TO PROGRAM EXOSKELETONS ACCORDING TO TASKS REQUIRED TO BE PERFORMED BY THEM
    • TABLE 13 MEDICAL EXOSKELETON MARKET FOR SOFTWARE , BY REGION, 2019-2026 (USD MILLION)

7 MEDICAL EXOSKELETON MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 14 MEDICAL EXOSKELETON MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 7.2 POWERED
    • 7.2.1 POWERED EXOSKELETONS ARE USUALLY POWERED BY ELECTRIC MOTORS, ACTUATORS, SENSORS, AND BATTERIES
    • TABLE 15 POWERED EXOSKELETON MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 PASSIVE
    • 7.3.1 PASSIVE EXOSKELETONS REQUIRE NO ELECTRIC POWER AND ARE SIMPLER IN COMPARISON TO POWERED EXOSKELETONS
    • TABLE 16 PASSIVE EXOSKELETON MARKET, BY REGION, 2019-2026 (USD MILLION)

8 MEDICAL EXOSKELETON MARKET, BY EXTREMITY

  • 8.1 INTRODUCTION
    • TABLE 17 MEDICAL EXOSKELETON MARKET, BY EXTREMITY, 2019-2026 (USD MILLION)
    • TABLE 18 MEDICAL EXOSKELETON MARKET, BY EXTREMITY, 2019-2026 (UNITS)
  • 8.2 LOWER EXTREMITY
    • 8.2.1 LOWER EXTREMITY EXOSKELETONS ARE DESIGNED TO PROVIDE PROTECTION, ASSISTANCE, AND SUPPORT TO LOWER LIMBS OF HUMAN BODY
    • TABLE 19 LOWER EXTREMITY MEDICAL EXOSKELETON MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 UPPER EXTREMITY
    • 8.3.1 UPPER EXTREMITY EXOSKELETONS PROVIDE SUPPORT TO UPPER LIMBS FOR STRENGTHENING OR AUGMENTATION
    • TABLE 20 UPPER EXTREMITY MEDICAL EXOSKELETON MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 8.4 FULL BODY
    • 8.4.1 FULL-BODY EXOSKELETONS ARE DESIGNED FOR HUMAN BODY STRENGTH AUGMENTATION
    • TABLE 21 FULL BODY MEDICAL EXOSKELETON MARKET, BY REGION, 2019-2026 (USD MILLION)

9 MEDICAL EXOSKELETON MARKET, BY STRUCTURE

  • 9.1 INTRODUCTION
  • 9.2 RIGID EXOSKELETONS
    • 9.2.1 RIGID EXOSKELETONS CAN DELIVER HIGHER FORCES QUICKLY AND ACCURATELY, EVEN IN EXTREME CASES OF PARALYSIS
  • 9.3 SOFT EXOSKELETONS
    • 9.3.1 SOFT EXOSKELETONS REDUCE RISKS OF INJURY, ARE EASIER TO FIT, AND IMPROVE MANEUVERABILITY

10 MEDICAL EXOSKELETON MARKET, BY MOBILITY

  • 10.1 INTRODUCTION
    • TABLE 22 MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2019-2026 (USD MILLION)
  • 10.2 STATIONARY
    • 10.2.1 STATIONARY EXOSKELETONS ARE MOSTLY USED IN MEDICAL APPLICATIONS
    • TABLE 23 STATIONARY MEDICAL EXOSKELETONS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 10.3 MOBILE
    • 10.3.1 MOBILE EXOSKELETONS PROVIDE EFFECTIVE AND REPETITIVE GAIT TRAINING FOR DISABLED PATIENTS
    • TABLE 24 MOBILE MEDICAL EXOSKELETONS MARKET, BY REGION, 2019-2026 (USD MILLION)

11 GEOGRAPHIC ANALYSIS

  • 11.1 INTRODUCTION
    • TABLE 25 MEDICAL EXOSKELETON MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 26 MEDICAL EXOSKELETON MARKET, BY REGION, 2019-2026 (UNITS)
  • 11.2 NORTH AMERICA
    • FIGURE 28 SNAPSHOT: EXOSKELETON MARKET IN NORTH AMERICA
    • TABLE 27 NORTH AMERICA: MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 28 NORTH AMERICA: MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 29 NORTH AMERICA: MEDICAL EXOSKELETON HARDWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 30 NORTH AMERICA: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 31 NORTH AMERICA: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2019-2026 (USD MILLION)
    • TABLE 32 NORTH AMERICA: MEDICAL EXOSKELETON MARKET, BY EXTREMITY, 2019-2026 (USD MILLION)
    • 11.2.1 US
      • 11.2.1.1 Increasing use of exoskeletons in healthcare to fuel market growth in US
    • TABLE 33 US: MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 34 US: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 35 US: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2019-2026 (USD MILLION)
    • 11.2.2 CANADA
      • 11.2.2.1 Growing geriatric population and surging demand for personal assistance exoskeletons to drive market growth in Canada
    • TABLE 36 CANADA: MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 37 CANADA: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 38 CANADA: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2019-2026 (USD MILLION)
  • 11.3 EUROPE
    • FIGURE 29 SNAPSHOT: MEDICAL EXOSKELETON MARKET IN EUROPE
    • TABLE 39 EUROPE: MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 40 EUROPE: MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 41 EUROPE: MEDICAL EXOSKELETON HARDWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 42 EUROPE: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 43 EUROPE: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2019-2026 (USD MILLION)
    • TABLE 44 EUROPE: MEDICAL EXOSKELETON MARKET, BY EXTREMITY, 2019-2026 (USD MILLION)
    • 11.3.1 UK
      • 11.3.1.1 Demand for exoskeletons in healthcare and personal assistance applications to support market growth
    • TABLE 45 UK: MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 46 UK: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 47 UK: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2019-2026 (USD MILLION)
    • 11.3.2 GERMANY
      • 11.3.2.1 Growing elderly population and increasing prevalence of diseases such as stroke are expected to drive market growth in Germany
    • TABLE 48 GERMANY: MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 49 GERMANY: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 50 GERMANY: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2019-2026 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 Rising geriatric population and growing incidences of chronic diseases are expected to propel demand for medical exoskeletons in France
    • TABLE 51 FRANCE: MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 52 FRANCE: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 53 FRANCE: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2019-2026 (USD MILLION)
    • 11.3.4 REST OF EUROPE (ROE)
    • TABLE 54 ROE: MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 55 ROE: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 11.4 ASIA
    • TABLE 56 ASIA: MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 57 ASIA: MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 58 ASIA: MEDICAL EXOSKELETON HARDWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 59 ASIA: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 60 ASIA: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2019-2026 (USD MILLION)
    • TABLE 61 ASIA: MEDICAL EXOSKELETON MARKET, BY EXTREMITY, 2019-2026 (USD MILLION)
    • 11.4.1 JAPAN
      • 11.4.1.1 Aging population and reduced workforce would fuel demand for exoskeletons in Japan in near future
    • TABLE 62 JAPAN: MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 63 JAPAN: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 64 JAPAN: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2019-2026 (USD MILLION)
    • 11.4.2 CHINA
      • 11.4.2.1 Emergence of new exoskeleton companies in China to augment market growth during forecast period
    • TABLE 65 CHINA: MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 66 CHINA: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 67 CHINA: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2019-2026 (USD MILLION)
    • 11.4.3 INDIA
      • 11.4.3.1 Initiation of various automotive manufacturing projects in India would fuel exoskeleton market growth in coming years
    • TABLE 68 INDIA: MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 69 INDIA: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 70 INDIA: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2019-2026 (USD MILLION)
    • 11.4.4 REST OF ASIA
    • TABLE 71 ROA: MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 72 ROA: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 73 ROA: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2019-2026 (USD MILLION)
  • 11.5 REST OF THE WORLD
    • TABLE 74 ROW: MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 75 ROW: MEDICAL EXOSKELETON HARDWARE MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 76 ROW: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 77 ROW: MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2019-2026 (USD MILLION)
    • TABLE 78 ROW: MEDICAL EXOSKELETON MARKET, BY EXTREMITY, 2019-2026 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
    • FIGURE 30 KEY DEVELOPMENTS OF PROMINENT PLAYERS OPERATING IN MEDICAL EXOSKELETON MARKET (2020-2021)
  • 12.2 MARKET SHARE ANALYSIS: MEDICAL EXOSKELETON MARKET, 2020
    • TABLE 79 DEGREE OF COMPETITION
  • 12.3 COMPANY EVALUATION QUADRANT
    • 12.3.1 STAR
    • 12.3.2 EMERGING LEADER
    • 12.3.3 PERVASIVE
    • 12.3.4 PARTICIPANT
    • FIGURE 31 MEDICAL EXOSKELETON MARKET: COMPANY EVALUATION QUADRANT, 2020 (OVERALL MARKET)
  • 12.4 COMPANY EVALUATION QUADRANT FOR EMERGING PLAYERS
    • 12.4.1 PROGRESSIVE COMPANY
    • 12.4.2 RESPONSIVE COMPANY
    • 12.4.3 DYNAMIC COMPANY
    • 12.4.4 STARTING BLOCK
    • FIGURE 32 MEDICAL EXOSKELETON MARKET: COMPANY EVALUATION QUADRANT, 2020 (EMERGING PLAYERS)
  • 12.5 COMPETITIVE BENCHMARKING
    • 12.5.1 OVERALL COMPANY FOOTPRINT
    • TABLE 80 OVERALL COMPANY FOOTPRINT
    • 12.5.2 COMPANY PRODUCT TYPE FOOTPRINT
    • TABLE 81 COMPANY PRODUCT TYPE FOOTPRINT
    • 12.5.3 COMPANY PRODUCT MOBILITY FOOTPRINT
    • TABLE 82 COMPANY PRODUCT MOBILITY FOOTPRINT
    • 12.5.4 COMPANY REGION FOOTPRINT
    • TABLE 83 COMPANY REGION FOOTPRINT
  • 12.6 COMPETITIVE SCENARIO
    • 12.6.1 PRODUCT OR SERVICE LAUNCHES
    • TABLE 84 PRODUCT LAUNCHES & DEVELOPMENTS, 2020-2021
    • 12.6.2 DEALS
    • TABLE 85 DEALS
    • 12.6.3 OTHERS
    • TABLE 86 OTHERS

13 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
  • 13.1 CYBERDYNE INC.
    • TABLE 87 CYBERDYNE INC.: BUSINESS OVERVIEW
    • FIGURE 33 CYBERDYNE INC.: COMPANY SNAPSHOT (2020)
  • 13.2 EKSO BIONICS
    • TABLE 88 EKSO BIONICS: BUSINESS OVERVIEW
    • FIGURE 34 COMPANY SNAPSHOT: EKSO BIONICS (2020)
  • 13.3 REWALK ROBOTICS
    • TABLE 89 REWALK ROBOTICS: BUSINESS OVERVIEW
    • FIGURE 35 COMPANY SNAPSHOT: REWALK ROBOTICS (2020)
  • 13.4 BIONIK LABORATORIES
    • TABLE 90 BIONIK LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 36 BIONIK LABORATORIES: COMPANY SNAPSHOT
  • 13.5 REX BIONICS
    • TABLE 91 REX BIONICS: BUSINESS OVERVIEW
  • 13.6 PARKER HANNIFIN CORP
    • TABLE 92 PARKER HANNIFIN CORP: BUSINESS OVERVIEW
    • FIGURE 37 COMPANY SNAPSHOT: PARKER HANNIFIN CORP (2020)
  • 13.7 B-TEMIA INC.
    • TABLE 93 B-TEMIA INC: BUSINESS OVERVIEW
  • 13.8 BIOVENTUS
    • TABLE 94 BIOVENTUS BUSINESS OVERVIEW
    • FIGURE 38 COMPANY SNAPSHOT: BIOVENTUS (2020)
  • 13.9 HOCOMA AG (A SUBSIDIARY OF DIH TECHNOLOGIES)
    • TABLE 95 HOCOMA AG: BUSINESS OVERVIEW
  • 13.10 WEARABLE ROBOTICS
    • TABLE 96 WEARABLE ROBOTICS: BUSINESS OVERVIEW
  • 13.11 OTHER KEY PLAYERS
    • 13.11.1 GOGOA MOBILITY ROBOTS
    • 13.11.2 EXOATLET
    • 13.11.3 MEDITOUCH
    • 13.11.4 SUITX
    • 13.11.5 MEDEXO ROBOTICS
    • 13.11.6 P & S MECHANICS
    • 13.11.7 MARSI BIONICS S.L.
    • 13.11.8 REHAB ROBOTICS
    • 13.11.9 FOURIER INTELLIGENCE
    • 13.11.10 MYOMO INC
    • 13.11.11 FOCAL MEDITECH
    • 13.11.12 HONDA MOTORS
    • 13.11.13 WANDERCRAFT
    • 13.11.14 BAMA TEKNOLOJI
    • 13.11.15 TWIICE
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 14.2 DISCUSSION GUIDE
  • 14.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4 AVAILABLE CUSTOMIZATIONS
  • 14.5 RELATED REPORTS
  • 14.6 AUTHOR DETAILS